DK0792163T3 - Acnebehandlings- og sårhelingspræparater indeholdende et pyruvat, en antioxidant og en blanding af fedtsyrer - Google Patents

Acnebehandlings- og sårhelingspræparater indeholdende et pyruvat, en antioxidant og en blanding af fedtsyrer

Info

Publication number
DK0792163T3
DK0792163T3 DK95937364T DK95937364T DK0792163T3 DK 0792163 T3 DK0792163 T3 DK 0792163T3 DK 95937364 T DK95937364 T DK 95937364T DK 95937364 T DK95937364 T DK 95937364T DK 0792163 T3 DK0792163 T3 DK 0792163T3
Authority
DK
Denmark
Prior art keywords
pyruvate
antioxidant
mixture
fatty acids
wound healing
Prior art date
Application number
DK95937364T
Other languages
Danish (da)
English (en)
Inventor
Alain Martin
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0792163T3 publication Critical patent/DK0792163T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95937364T 1994-11-16 1995-10-05 Acnebehandlings- og sårhelingspræparater indeholdende et pyruvat, en antioxidant og en blanding af fedtsyrer DK0792163T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34057994A 1994-11-16 1994-11-16
US08/446,988 US5646190A (en) 1991-03-01 1995-05-22 Acne treating-wound healing compositions and methods for preparing and using same
PCT/US1995/012853 WO1996014868A1 (en) 1994-11-16 1995-10-05 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids

Publications (1)

Publication Number Publication Date
DK0792163T3 true DK0792163T3 (da) 2002-09-09

Family

ID=26992170

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937364T DK0792163T3 (da) 1994-11-16 1995-10-05 Acnebehandlings- og sårhelingspræparater indeholdende et pyruvat, en antioxidant og en blanding af fedtsyrer

Country Status (11)

Country Link
US (1) US5646190A (es)
EP (1) EP0792163B1 (es)
JP (1) JPH10509451A (es)
AU (1) AU697404B2 (es)
CA (1) CA2204145A1 (es)
DE (1) DE69526742T2 (es)
DK (1) DK0792163T3 (es)
ES (1) ES2176343T3 (es)
MX (1) MX9703354A (es)
NZ (1) NZ295852A (es)
WO (1) WO1996014868A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US7438896B2 (en) * 1995-09-20 2008-10-21 N.V. Perricone Llc Method of skin care using lipoic and ascorbic acids
DE19724622A1 (de) * 1997-06-11 1998-12-17 Beiersdorf Ag Verwendung von cis-6-Hexadecensäure zur Behandlung von Psoriasis, Allergien und Autoimmunerkrankungen
US6365623B1 (en) * 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
US5980920A (en) * 1998-03-02 1999-11-09 Lindquist; Niels L. Antioxidant compositions
WO1999059580A1 (fr) 1998-05-15 1999-11-25 Showa Denko K.K. Agents preventifs/therapeutiques pour les affections cutanees
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
US6541517B1 (en) 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
EP1325737B1 (en) * 2000-10-12 2009-12-16 Kao Corporation Skin pore minimizers and skin elasticity improvers
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US6743433B2 (en) * 2001-07-06 2004-06-01 Nicholas V. Perricone Treatment of acne using alkanolamine compositions
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
US20030198616A1 (en) * 2002-04-23 2003-10-23 Combe Incorporated Moisturizing skin gel and method
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
KR100673044B1 (ko) * 2003-05-16 2007-01-22 로터스 파마세티컬 리미티드 컴퍼니 경피 투여용 국소 조성물
US20060147507A1 (en) * 2005-01-04 2006-07-06 Marie Cammarata Hot flash treatment system
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
WO2008060949A2 (en) * 2006-11-09 2008-05-22 Stc.Unm Compounds with anti-androgenic activity and the use thereof
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010119966A1 (ja) * 2009-04-17 2010-10-21 シャボン玉石けん株式会社 抗ウイルス剤及び洗浄剤
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US8470880B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINO-QUINOLINES AS KINASE INHIBITORS
EP2857025A1 (en) * 2013-10-02 2015-04-08 Special Water Patents B.V. Wound treatment composition
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法
WO2018175334A1 (en) 2017-03-20 2018-09-27 Es Biosolutions, Inc. Compositions and methods for skin treatments
MX2022015123A (es) * 2020-05-29 2023-01-11 Ind Alen S A De C V Formulaciones similares a cera de materiales de origen natural y su metodo de preparacion.

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887702A (en) * 1973-08-30 1975-06-03 Mildred Baldwin Composition and method for treating fingernails and toenails
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US3984566A (en) * 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
US3988470A (en) * 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
JPS5132738A (ja) * 1974-09-13 1976-03-19 Mikio Nakanishi Kokagakusumotsugunohigaioboshisuru hoho
US4158057A (en) * 1975-03-28 1979-06-12 Stanko Ronald T Prevention of the accumulation of fatty deposits in the liver
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4197316A (en) * 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4170821A (en) * 1977-12-02 1979-10-16 Warner-Lambert Company Razor cartridges
US4284630A (en) * 1978-03-22 1981-08-18 Yu Ruey J Stabilized water-in-oil emulsions
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
JPS5783287A (en) * 1980-11-14 1982-05-25 Kyowa Hakko Kogyo Co Ltd Elimination of hydrogen peroxide
US4812479A (en) * 1981-04-01 1989-03-14 The Montefiore Hospital Society Of Western Pennsylvania, Inc. Method for preventing body fat deposition in mammals
US4548937A (en) * 1981-04-01 1985-10-22 Montefiore Hospital Method for preventing body fat deposition in mammals
US4645764A (en) * 1981-04-01 1987-02-24 Montefiore Hospital Method for preventing body fat deposition in animals
US4351835A (en) * 1981-04-01 1982-09-28 Montefiore Hospital Method for preventing body fat deposition in mammals
US4415576A (en) * 1981-04-01 1983-11-15 Montefiore Hospital Method for preventing body fat deposition in mammals
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell
US4454159A (en) * 1981-12-28 1984-06-12 Albert Musher Dermatological treatment preparations
DE3201511A1 (de) * 1982-01-20 1983-07-28 Henkel Kgaa Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten
US4451482A (en) * 1982-04-22 1984-05-29 Shell Oil Company Method of preventing or ameliorating pyrethroid skin sensory stimulation
US4521375A (en) * 1982-11-23 1985-06-04 Coopervision, Inc. Sterilizing treatment with hydrogen peroxide and neutralization of residual amounts thereof
EP0163696B1 (en) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Use of a bioadhesive
DE3586844T2 (de) * 1984-06-22 1994-03-17 Richard L Veech Elektrolytlösungen und deren (in vivo) verwendung.
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4935495A (en) * 1984-12-21 1990-06-19 Oncogen Monoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomas
US4696917A (en) * 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
CS262822B1 (en) * 1986-10-03 1989-04-14 Kovar Jan Synthetic medium for the cultivation of myelomic cells
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E
US4847071A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4847072A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
TR22895A (tr) * 1988-05-02 1988-10-11 Permatik Celik Ve Plastik San Platform ve bashk kisimlarinin tamami yardimci tiras malzemesi katkisiyla ueretilen,sulu ortamda kaygan zemin olusturan,bir veya cok bicakh tiras ueniteleri
KR910000101A (ko) * 1988-06-02 1991-01-29 유다까 미시마 효소형성 억제제
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
CA2018471A1 (en) * 1989-07-28 1991-01-28 Ian W. Kellaway Mucoadhesive hydrogels delivery system
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
PH31403A (en) * 1991-03-01 1998-10-29 Warner Lambert Co Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.
WO1993010776A1 (en) * 1991-11-26 1993-06-10 Warner-Lambert Company Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
US5296307A (en) * 1992-05-08 1994-03-22 Electric Power Research Institute, Inc. Laminated paper polyolefin paper composite

Also Published As

Publication number Publication date
EP0792163B1 (en) 2002-05-15
DE69526742D1 (de) 2002-06-20
ES2176343T3 (es) 2002-12-01
AU3949295A (en) 1996-06-06
JPH10509451A (ja) 1998-09-14
US5646190A (en) 1997-07-08
EP0792163A1 (en) 1997-09-03
NZ295852A (en) 1998-08-26
WO1996014868A1 (en) 1996-05-23
CA2204145A1 (en) 1996-05-23
MX9703354A (es) 1998-02-28
DE69526742T2 (de) 2002-11-21
AU697404B2 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
DK0792163T3 (da) Acnebehandlings- og sårhelingspræparater indeholdende et pyruvat, en antioxidant og en blanding af fedtsyrer
DK0754052T3 (da) Antiviral sårhelende sammensætning indeholdende et pyruvat, en antioxidant, en blanding af fedtsyrer og en antiviral forbindelse
DE69502425D1 (de) Herstellung von Polybutenen
NO973283L (no) Konjugater av terapeutisk forbindelse og fettsyre
AU4156493A (en) Compositions containing retinoic acids and tocopherol
AU4652593A (en) Surgical face mask support apparatus and method
AU4840493A (en) Methods for treating suturable wounds by use of sutures and cyanoacrylate adhesives
AU4124997A (en) Fatty acid treatment
AU4775597A (en) Skin care compositions containing an acid and a retinoid
ES2157470T3 (es) Amidas arilicas y heteroarilicas de tetrahidronaftaleno, cromano, tiocromano y acidos 1,2,3,4-tetrahidroquinolin-carboxilicos que tienen actividad biologica de tipo retinoide.
AU7512994A (en) Lateral field emitter device and method of manufacturing same
DE69417496D1 (de) Sulfonierung von Fettsäureestern
AU6329890A (en) Combined surgical needle-suture device and method for its manufacture
NO973288D0 (no) Blanding og anvendelse
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
DE69528440D1 (de) 5-Aminolävulinsäure produzierender Mikroorganismus
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AU7222598A (en) Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
BR9600254A (pt) Composto processo para a sua preparação seus usos método para o tratamento de arritmias e medicamento contendo o mesmo
AU3893495A (en) Solution sterilization system and method of operation
AU4220193A (en) Deazaaminopterins for treatment of inflammation
DE69317893D1 (de) Percarbonsäure
AU3374593A (en) Improved high protein liquid nutrition for patients with elevated wound healing requirements
AU7799494A (en) Compact projection illumination system and method of using same
AU5306590A (en) Method of killing pests